The complex interactions between the oxytocin system and estrogen signaling pathways highlight oxytocin’s multifaceted roles in both breast cancer progression and patient resilience, underscoring the need for additional research to unravel the nuances of oxytocin signaling in cancer. Here, OXT is linked to breast cancer.